HER (erbB) tyrosine kinase inhibitors in the treatment of breast cancer

• 1 June 2002
• journal article
• Published by Elsevier in Seminars in Oncology
• Vol. 29  (3 Suppl 11) , 4-10
• https://doi.org/10.1053/sonc.2002.34047

Abstract

Keywords

• PROTEINS
• TYROSINE KINASES
• SURVIVAL
• BREAST
• CARCINOMA
• ONCOGENIC
• HER2
• ANTIBODY